美团(03690.HK)逆涨逾半成再破顶 获瑞信升价至135元
恒指公司CEO关永盛接受媒体查询时透露,拟於未来一两周就同股不同权及第二上市股份是否有资格纳入指数等问题进行谘询,预计5月会有结果,届时阿里巴巴(09988.HK)、小米(01810.HK)及美团点评(03690.HK)会否「染蓝」拭目以待。
瑞信将美团目标价上调12.5%至135元,重申「跑赢大市」评级,以反映公司盈利透明度改善。该股反覆三连涨,今天更逆市升破上月初所创上市高位107.4元,现造109.5元,续升5.1%,成交增至2,304万股,涉资24.74亿元。
小米反覆回升0.7%,报10.98元。不过,阿里股价由纪录高位回软,最低见209.2元,现造210.6元,吐近0.6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.